Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $147
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Tenet Healthcare (NYSE:THC) and raises the price target from $113 to $147.
May 02, 2024 | 6:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on Tenet Healthcare and raises the price target from $113 to $147.
The upgrade in price target by Barclays reflects a positive outlook on Tenet Healthcare's stock, suggesting an expectation of strong performance. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100